Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Toxicol In Vitro. 2013 Apr 18;27(6):1626–1633. doi: 10.1016/j.tiv.2013.04.006

Figure 5.

Figure 5

Western blot analysis and quantitative densitometry of cleaved caspase-3 expression in HT-29 cells treated with various concentrations of PPLGM. A) Treatment (24 hours) of HT-29 cells with PPLGM (0-20 μM) resulted in enhanced cleaved caspase-3 expression. B) Densitometry shows the results of PPLGM treatment on cleaved caspase-3 expression normalized to total caspase-3 in three replicate experiments ± standard deviation, where * denotes statistical significance (p<0.05).